Masimo Corporation (LON:0JZ2)
135.65
+4.68 (3.57%)
Feb 12, 2026, 3:31 PM GMT
Masimo Market Cap
Masimo has a market cap or net worth of 5.32 billion as of February 12, 2026. Its market cap has decreased by -29.51% in one year.
Market Cap
5.32B
Enterprise Value
5.52B
Revenue
1.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
135.65
Market Cap Chart
Since August 8, 2007, Masimo's market cap has increased from 541.95M to 5.32B, an increase of 880.96%. That is a compound annual growth rate of 13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 5.32B | 2.42% |
| Dec 31, 2025 | 5.19B | -26.58% |
| Dec 31, 2024 | 7.07B | 45.39% |
| Dec 29, 2023 | 4.86B | -24.67% |
| Dec 30, 2022 | 6.45B | -45.94% |
| Dec 31, 2021 | 11.94B | 10.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.75B |
| GSK plc | 88.21B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.40B |
| Hikma Pharmaceuticals | 3.41B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |